Back to search
Treatment of Lipoprotein Disorder
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Treatment of Lipoprotein Disorder trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Treatment of Lipoprotein Disorder trials you may qualify forThe purpose of the study is to evaluate the safety, tolerability, pharmacokinetics (PK), and pharmacodynamics (PD) of single and multiple ascending doses of AZD…
Statins are the cornerstone of cardiovascular disease (CVD) prevention through the lowering of low-density lipoprotein cholesterol (LDL-C). While the benefits o…
Hypercholesterolemia is recognized as the major driver for cardiovascular morbidity and mortality. To help address this in our community, Atlantic Medical Group…
The goal of this implementation trial is to learn if providing education to doctors and patients who have had a heart event works to prevent future heart proble…
The goal of this clinical trial is to learn if propolis administration works to change the level of Low Density Lipoprotein (LDL) and High Density Lipoprotein c…
This is an early phase 1, open-label, single-center, dose-escalation, pilot trial to evaluate the safety and efficacy of an intravenous infusion of NGGT006 in h…
The purpose of this clinical trial is to find out whether one type of fish oil works better than another at improving metabolic health in people who are at high…
The goal of this clinical trial is to test whether one pill that combines ezetimibe, rosuvastatin, and amlodipine can safely lower cholesterol and blood pressur…
The purpose of this study is to evaluate pharmacodynamics (PD) of AZD0780 compared with placebo by assessment of low-density lipoprotein-cholesterol (LDL-C) lev…